Summary:
American Institute of Research is currently conducting a Phase 4, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects with Overactive Bladder (OAB)
Qualified Participants Must:
• Be 65 years of age or older
•
Be willing and able to complete the micturition diary and questionnaires correctly
•
Have symptoms of wet OAB (urinary frequency and urgency with incontinence) for greater than or equal to 3 months
Qualified Participants May Receive:
All study related exams and medications will be provided to you at no cost. Participants may also receive compensation for their time and travel.